Bausch Health Companies Inc. filings document regulatory disclosures for a global diversified pharmaceutical company incorporated in British Columbia. The record includes Form 8-K reports for quarterly and annual operating results, Regulation FD updates, clinical-program disclosures, material agreements, debt exchanges and credit-agreement refinancing involving Bausch Health and its subsidiaries, including Bausch + Lomb.
Proxy materials describe annual meeting matters, director elections, auditor approval, executive compensation votes and governance procedures. Other current reports address compensatory arrangements, including performance share unit settlement terms, and capital-structure disclosures tied to senior secured notes, guarantees, collateral arrangements and refinancing transactions.
Paulson & Co. Inc. reported an initial Form 3 disclosing that certain funds it manages hold 70,755,869 shares of Bausch Health Companies Inc. (BHC). The filing, dated 08/14/2025, lists Paulson as the investment manager and notes John Paulson as the controlling person; the shares are indirectly owned by the Funds.
John Paulson, a director and the controlling person of Paulson Capital Inc., reported purchases of Bausch Health Companies common stock executed by funds he manages. The filings show three purchases: 2,000,000 shares at $6.35, 1,156,640 shares at $6.88, and 86,409 shares at $7.06, totaling 3,243,049 shares. After these transactions the reporting person’s indirect beneficial ownership is stated as 36,034,751 shares. The shares are held by managed funds and the report includes a disclaimer that the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest. No derivative securities were reported on the form.
Bausch Health is asking shareholders to ratify a shareholder rights plan at a Special Meeting to be held via webcast on October 7, 2025 (record shareholders as of August 18, 2025 may vote). The Board adopted the Rights Plan on April 14, 2025 and issued one Right for each Voting Share outstanding at the Record Time. The Rights are intended to ensure all shareholders are treated equally in any unsolicited take-over bid and to discourage creeping acquisitions.
The Rights convert into purchase rights after a defined Separation Time if a person becomes an Acquiring Person (generally at a 20% Beneficial Ownership threshold). The Exercise Price is set at three times the 20-day average Market Price, and a Flip‑In Event can lead to significant dilution for an acquiror. The TSX has given conditional acceptance, and the Rights Plan requires reconfirmation by shareholders every third annual meeting to remain effective.